openPR Logo
Press release

Leukemia Therapeutic Market Trends, Research Report, Growth, Opportunities and Forecast 2023-2029

04-03-2023 12:55 PM CET | Health & Medicine

Press release from: Orion Market Research

Leukemia Therapeutic Market Trends, Research Report, Growth,

The global leukemia therapeutic market is anticipated to grow at a substantial CAGR of 7.3% during the forecast period. According to Cancer.org, the estimated number of new cases registered in 2020 by Acute lymphocytic leukemia was 6,150, chronic lymphocytic leukemia was 21,040, acute myeloid leukemia was 19,940, and chronic myeloid leukemia a new case was 8,450. The major risk factor responsible for the rising number of cancer patients is the consumption of cigarettes, and alcohol other risk factors include type 2 diabetes, excess body weight, and a family history of cancer. With the rise in the number of cancer patients across the globe, the demand for leukemia therapeutics rises in the forthcoming year.

A full report of Leukemia Therapeutic Market is available at: https://www.omrglobal.com/industry-reports/leukemia-therapeutics-market

The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in June 2021, Jazz Pharmaceuticals plc., announced the approval of Rylaze, from US FDA., for the treatment of acute lymphoblastic leukemia(ALL) or lymphoblastic lymphoma (LBL). This drug is specially launched for children who cannot tolerate E. coli-derived asparaginase medicine. In November 2021, Pfizer Inc., announced a collaboration with Trillium Therapeutics, to bring an impressive portfolio that includes biologics that are designed to enhance the ability of patients innate immune system to detect and destroy cancer cells. Its two lead molecules, TTI-622 and TTI-621, block the signal regulatory protein, which is developed as a key immune checkpoint in hematological malignancies.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/leukemia-therapeutics-market

Market Coverage

The market number available for - 2021-2028
Base year- 2021
Forecast period- 2021-2028
Segment Covered- by type, by drugs type
Regions Covered- North America, Europe, Asia-Pacific, Rest of the World
Competitive Landscape- are Astellas Pharma Inc., Biogen Inc., Bristol Myers Squibb, Cephalon A/S, Daiichi Sankyo, Eisai Co. Ltd., F. Hoffmann-La Roche Ltd., Novartis, and others.

Key questions addressed by the report

What is the market growth rate?
Which segment/region dominates the market in the base year?
Which segment/region will project the fastest growth in the market?
How has COVID-19 impacted the market?
o Recovery Timeline

o Deviation from the pre-COVID forecast

o Most affected region/segment

Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?

Global Leukemia Therapeutic Market- Segmentation

By Type

Acute myeloid leukemia
Chronic myeloid leukemia
Acute lymphocytic leukemia
Chronic lymphocytic leukemia

By Drugs Type

Acute Lymphoblastic Leukemia Drugs
Myelogenous Leukemia Drug
Chronic Lymphocytic Leukemia Drug
Acute Promyelocytic Leukemia Drug
Other Drug

Leukemia Therapeutic Market- Segment by Region

North America

United States
Canada

Europe

Germany
United Kingdom
France
Spain
Italy
Rest of Europe

Asia-Pacific

China
Japan
India
Rest of Asia-Pacific

Rest of the World

Middle East & Africa
Latin America

Company Profiles

Abbott Laboratories
Agios Pharmaceuticals
Astellas Pharma Inc.
Biogen Inc
Bristol Myers Squibb
Cephalon A/S
Daiichi Sankyo
Eisai Co. Ltd
Hoffmann-La Roche Ltd
GSK Plc
Innate Pharma Sa
Johnson & Johnson
Merck KGgaAa (The Merck Group)

Reasons to Buying From us -

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

Visit more report at

https://www.culturespace.co.kr/news-%eb%ac%b8%ed%99%94%e8%a1%97/b2b-%ec%a0%84%ec%9e%90%ec%83%81%ea%b1%b0%eb%9e%98-%ec%8b%9c%ec%9e%a5-%eb%b3%b4%ea%b3%a0%ec%84%9c-2023-%ec%a3%bc%ec%9a%94-%ed%94%8c%eb%a0%88%ec%9d%b4%ec%96%b4%eb%b3%84-%eb%8f%99%ed%96%a5-%ea%b7%9c/40349/

https://www.asiatimeskorea.com/press-release/bakeware-%ec%8b%9c%ec%9e%a5-%ec%a0%90%ec%9c%a0%ec%9c%a8-2023-%eb%8f%99%ed%96%a5-%ec%a3%bc%ec%9a%94-%ec%97%85%ec%b2%b4-%ec%82%b0%ec%97%85-%eb%b6%84%ec%84%9d-%eb%b0%8f-%ec%98%88%ec%b8%a12023-2029/404382/

https://www.diario-ya.com/regionales/2023-%e5%b9%b4%e9%93%b6%e8%a1%8c%e4%bf%a1%e6%81%af%e4%ba%ad%e5%b8%82%e5%9c%ba%e6%8a%a5%e5%91%8a%ef%bc%9a%e6%8c%89%e4%b8%bb%e8%a6%81%e5%8f%82%e4%b8%8e%e8%80%85%e3%80%81%e8%b6%8b%e5%8a%bf%e3%80%81/532248/

https://sportmsr.com/%d8%a7%d8%aa%d8%ac%d8%a7%d9%87%d8%a7%d8%aa-%d8%b3%d9%88%d9%82-%d8%ac%d8%b1%d8%a7%d8%ad%d8%a9-%d8%a7%d9%84%d8%b3%d9%85%d9%86%d8%a9-%d8%8c-%d8%a7%d9%84%d8%aa%d9%88%d9%82%d8%b9%d8%a7%d8%aa-%d8%a7%d9%84/

https://monblogapple.com/2023/03/20/part-de-marche-du-systeme-de-surveillance-de-la-pression-des-pneus-automobiles-croissance-de-lindustrie-rapport-danalyse-2029/

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Leukemia Therapeutic Market Trends, Research Report, Growth, Opportunities and Forecast 2023-2029 here

News-ID: 2997649 • Views:

More Releases from Orion Market Research

Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, …
Infrastructure as Code (IaC) Service Market was valued at approximately USD 0.932 billion, and it's projected to expand to around USD 7.509 billion by 2033, achieving a robust CAGR of 23.2% from 2024 to 2033. Infrastructure as Code (IaC) Service Market Overview The Infrastructure as Code (IaC) Service Market is experiencing remarkable expansion, fueled by the escalating need for scalable, automated infrastructure deployment across cloud and enterprise environments. In 2023, the market
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to Understanding the Process
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to …
Ultra High‐Performance Liquid Chromatography (UHPLC) Columns Market is estimated to be valued at USD 2.5 billion, and is projected to grow to approximately USD 4.8 billion by 2033, representing a compound annual growth rate (CAGR) of about 7.8% from 2024 to 2033. Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market Overview The UHPLC columns market is on a strong growth trajectory, fueled by increasing demand for rapid, high-resolution analytical techniques across pharmaceuticals, biotechnology,
Property Management Service Market Rising Demand and Growth Forecast Through 2033
Property Management Service Market Rising Demand and Growth Forecast Through 203 …
Property Management Service Market was valued at approximately USD 17.3 billion. It is anticipated to reach around USD 32.0 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2033. Property Management Service Market Overview The Property Management Service Market is witnessing steady growth due to increasing urbanization, rising investments in real estate, and a growing demand for outsourced property management solutions. Property owners are increasingly
5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSilicon Technologies Co., Ltd., ZTE Corporation,
5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSili …
The global 5G chipset market was valued at USD 33.75 billion in 2024 and is projected to reach USD 502.66 billion by 2033, growing at a compound annual growth rate (CAGR) of 35% from 2025 to 2033. 5G Chipset Market Overview The 5G chipset market is experiencing rapid growth, driven by the global rollout of 5G networks and the increasing demand for high-speed, low-latency connectivity across various applications, including smartphones, IoT

All 5 Releases


More Releases for Leukemia

The Impact Of Increasing Leukemia Prevalence On The Leukemia Therapeutics Market …
The Leukemia Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Leukemia Therapeutics Market Size During the Forecast Period? In recent times, the market size for leukemia therapeutics has seen robust growth. It is projected to increase from $17.57 billion in 2024
Leukemia Therapeutics Market - Revolutionizing Leukemia Care: Cutting-Edge Thera …
Newark, New Castle, USA: The "Leukemia Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Leukemia Therapeutics Market: https://www.growthplusreports.com/report/leukemia-therapeutics-market/7759 This latest report researches the industry structure, sales, revenue,
Acute Lymphoblastic Leukemia Therapeutics Market Size, Acute Lymphoblastic Leuke …
Acute Lymphoblastic Leukemia Therapeutics Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Acute Lymphoblastic Leukemia Therapeutics research data, benefit, gross margin,
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, T …
Orbisreserach.Com Adds “H1 Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Market Pipeline Review 2017 Trend Analysis Report Report” To Its Research Database Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2017, provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) (Oncology) pipeline landscape. Chronic myeloid leukemia (CML), also known as chronic myelogenous leukemia, is a type of cancer that starts in the blood-forming cells of the
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical T …
ReportsWorldwide has announced the addition of a new report title Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports. GlobalData's clinical trial report, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) clinical trials scenario. This report provides top line data relating to
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Tri …
ReportsWorldwide has announced the addition of a new report title Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports. GlobalData's clinical trial report, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) clinical trials scenario. This report provides top line data relating to